CY2011007I2 - Οφθαλμικες σταγονες - Google Patents
Οφθαλμικες σταγονεςInfo
- Publication number
- CY2011007I2 CY2011007I2 CY2011007C CY2011007C CY2011007I2 CY 2011007 I2 CY2011007 I2 CY 2011007I2 CY 2011007 C CY2011007 C CY 2011007C CY 2011007 C CY2011007 C CY 2011007C CY 2011007 I2 CY2011007 I2 CY 2011007I2
- Authority
- CY
- Cyprus
- Prior art keywords
- eye drops
- drops
- eye
- Prior art date
Links
- 239000003889 eye drop Substances 0.000 title 1
- 229940012356 eye drops Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000277554 | 2000-09-13 | ||
| PCT/JP2001/007928 WO2002022131A1 (fr) | 2000-09-13 | 2001-09-13 | Collyre |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CY2011007I1 CY2011007I1 (el) | 2014-04-09 |
| CY2011007I2 true CY2011007I2 (el) | 2015-08-05 |
Family
ID=18762864
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100235T CY1113200T1 (el) | 2000-09-13 | 2011-02-28 | Οφθαλμικες σταγονες |
| CY2011007C CY2011007I2 (el) | 2000-09-13 | 2011-07-28 | Οφθαλμικες σταγονες |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111100235T CY1113200T1 (el) | 2000-09-13 | 2011-02-28 | Οφθαλμικες σταγονες |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20040097592A1 (el) |
| EP (1) | EP1321144B1 (el) |
| KR (1) | KR100854056B1 (el) |
| CN (1) | CN1243548C (el) |
| AT (1) | ATE490761T1 (el) |
| AU (1) | AU2001286210A1 (el) |
| CA (1) | CA2422031C (el) |
| CY (2) | CY1113200T1 (el) |
| DE (1) | DE60143615D1 (el) |
| DK (1) | DK1321144T3 (el) |
| ES (1) | ES2357551T3 (el) |
| NO (1) | NO332650B1 (el) |
| PT (1) | PT1321144E (el) |
| WO (1) | WO2002022131A1 (el) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001286210A1 (en) * | 2000-09-13 | 2002-03-26 | Asahi Glass Company, Limited | Eye drops |
| KR101027454B1 (ko) * | 2002-08-23 | 2011-04-06 | 산텐 세이야꾸 가부시키가이샤 | 라타노프로스트를 유효 성분으로 하는 안정한 점안액 |
| US7074827B2 (en) * | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
| EP1666043B1 (en) * | 2003-07-31 | 2009-12-02 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
| CN100484528C (zh) | 2003-11-07 | 2009-05-06 | 千寿制药株式会社 | 含有前列腺素的药物组合物 |
| KR101305649B1 (ko) * | 2004-12-09 | 2013-09-09 | 산텐 세이야꾸 가부시키가이샤 | 분자 내에 불소 원자를 갖는 프로스타글란딘 함유 제품 |
| CA2592474C (en) * | 2004-12-24 | 2013-08-13 | Santen Pharmaceutical Co., Ltd. | Prostaglandin f2.alpha. derivative-containing product |
| GB0501192D0 (en) * | 2005-01-20 | 2005-03-02 | Resolution Chemicals Ltd | Stable prostaglandin-containing compositions |
| PT1864666E (pt) | 2005-03-31 | 2012-09-06 | Santen Pharmaceutical Co Ltd | Agente protector para célula neuronal retiniana contendo derivado de prostaglandina f2 alfa como ingrediente activo |
| WO2006112313A1 (ja) | 2005-04-13 | 2006-10-26 | Ube Industries, Ltd. | インダゾール誘導体を有効成分として含む網膜神経細胞保護剤 |
| WO2007105691A1 (ja) * | 2006-03-13 | 2007-09-20 | R-Tech Ueno, Ltd. | 水性組成物 |
| FR2912207B1 (fr) * | 2007-02-01 | 2012-10-26 | Air Liquide | Procede et appareil de production de monoxyde de carbone par distillation cryogenique |
| CN101646441B (zh) * | 2007-03-29 | 2012-09-12 | 参天制药株式会社 | 含有氟米龙的混悬型滴眼剂 |
| EP1985298A1 (en) * | 2007-04-24 | 2008-10-29 | Azad Pharma AG | Ophtalmic oil-in-water emulsions containing prostaglandins |
| TWI544927B (zh) | 2008-03-17 | 2016-08-11 | 愛爾康研究有限公司 | 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物 |
| JP5661456B2 (ja) | 2008-04-23 | 2015-01-28 | 大塚製薬株式会社 | 点眼剤及び使用方法 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US20110136898A1 (en) * | 2008-08-05 | 2011-06-09 | University College Cork, National University Of Ireland, Cork | Treatment of retinal degeneration |
| EP2398443A2 (en) * | 2009-02-20 | 2011-12-28 | Micro Labs Limited | Storage stable prostaglandin product |
| EP2269575A1 (en) | 2009-06-30 | 2011-01-05 | Santen Pharmaceutical Co., Ltd | Method for improving bioavailability of latanoprost |
| US20110136872A1 (en) * | 2009-12-09 | 2011-06-09 | Burk Robert M | Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| ES2391721T3 (es) * | 2010-03-01 | 2012-11-29 | Laboratorios Salvat, S.A. | Disoluciones acuosas transparentes de acetónido de fluocinolona para el tratamiento de la infamación de oído |
| EP2452669A1 (en) | 2010-10-29 | 2012-05-16 | Omnivision GmbH | Ophthalmic composition |
| EP2567689A1 (en) * | 2011-09-12 | 2013-03-13 | Visiotact Pharma | Ophthtalmic compositions comprising prostaglandin F2 alpha derivatives and hyaluronic acid |
| KR102068858B1 (ko) * | 2012-06-08 | 2020-01-21 | 라이온 가부시키가이샤 | 점막용 조성물 |
| CN104288092A (zh) * | 2013-07-16 | 2015-01-21 | 广东东阳光药业有限公司 | 拉坦前列素滴眼剂 |
| CN104622798B (zh) * | 2014-12-05 | 2017-12-22 | 广东东阳光药业有限公司 | 一种含有他氟前列素的滴眼液及其制备方法 |
| WO2018033854A1 (en) | 2016-08-15 | 2018-02-22 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition and a method for treating ocular hypertension and glaucoma |
| EP3603642B1 (en) * | 2017-03-27 | 2024-01-10 | Alcon Inc. | Pharmaceutical preparation |
| US20210282965A1 (en) | 2018-07-09 | 2021-09-16 | Warszawskie Zaklady Farmaceutyczne Polfa Sa | Opthalmic dispensing device |
| CN113227304A (zh) * | 2018-09-21 | 2021-08-06 | Ps治疗有限公司 | 人工泪液、隐形眼镜和药物载体组合物及其使用方法 |
| JP2022512788A (ja) | 2018-10-25 | 2022-02-07 | ネクスモス カンパニー リミテッド | アプタミンｃを有効成分として含む点眼液組成物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310543A (en) * | 1980-10-09 | 1982-01-12 | Hoffmann-La Roche Inc. | Prostaglandin compositions |
| GB2209939B (en) * | 1987-09-18 | 1992-01-02 | R Tech Ueno Ltd | The use of 13,14-dihydro-15-keto-prostaglandins as ocular hypotensive agents |
| WO1989006130A1 (en) * | 1987-12-25 | 1989-07-13 | Santen Pharmaceutical Co., Ltd. | Antiallergic eye drop |
| US5565492A (en) * | 1988-07-18 | 1996-10-15 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| AU665287B2 (en) * | 1992-12-21 | 1995-12-21 | Alcon Laboratories, Inc. | Prostaglandin combinations in glaucoma therapy |
| US5486540A (en) * | 1993-10-28 | 1996-01-23 | Allergan, Inc. | Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| ATE221048T1 (de) * | 1996-09-17 | 2002-08-15 | Asahi Glass Co Ltd | Fluorierte prostaglandinderivate und medikamente |
| JP3480549B2 (ja) * | 1996-12-26 | 2003-12-22 | 参天製薬株式会社 | ジフルオロプロスタグランジン誘導体およびその用途 |
| AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
| JP2002520368A (ja) * | 1998-07-14 | 2002-07-09 | アルコン ラボラトリーズ， インコーポレイテッド | プロスタグランジン製品 |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| AU2183900A (en) * | 1998-12-24 | 2000-07-31 | Alcon Laboratories, Inc. | Ep4 receptor agonists for treatment of dry eye |
| ATE261738T1 (de) * | 1999-01-19 | 2004-04-15 | Upjohn Co | Packungsverfahren für oxidationsempfindliche medikamente |
| AU2001286210A1 (en) * | 2000-09-13 | 2002-03-26 | Asahi Glass Company, Limited | Eye drops |
| TW586946B (en) * | 2000-12-22 | 2004-05-11 | Novartis Ag | Process to improve stability |
| EP1666043B1 (en) * | 2003-07-31 | 2009-12-02 | Santen Pharmaceutical Co., Ltd. | Product containing prostaglandin |
| US20050049311A1 (en) * | 2003-09-03 | 2005-03-03 | Pharmacia & Upjohn Company | Medicinal products comprising prostaglandin compositions and methods of packaging such compositions |
-
2001
- 2001-09-13 AU AU2001286210A patent/AU2001286210A1/en not_active Abandoned
- 2001-09-13 DK DK01965597.6T patent/DK1321144T3/da active
- 2001-09-13 DE DE60143615T patent/DE60143615D1/de not_active Expired - Lifetime
- 2001-09-13 AT AT01965597T patent/ATE490761T1/de active
- 2001-09-13 CN CNB018156177A patent/CN1243548C/zh not_active Ceased
- 2001-09-13 US US10/380,401 patent/US20040097592A1/en not_active Abandoned
- 2001-09-13 PT PT01965597T patent/PT1321144E/pt unknown
- 2001-09-13 KR KR1020037003605A patent/KR100854056B1/ko active IP Right Review Request
- 2001-09-13 CA CA2422031A patent/CA2422031C/en not_active Expired - Lifetime
- 2001-09-13 EP EP01965597A patent/EP1321144B1/en not_active Expired - Lifetime
- 2001-09-13 WO PCT/JP2001/007928 patent/WO2002022131A1/ja active Application Filing
- 2001-09-13 ES ES01965597T patent/ES2357551T3/es not_active Expired - Lifetime
-
2003
- 2003-03-12 NO NO20031138A patent/NO332650B1/no not_active IP Right Cessation
-
2007
- 2007-06-26 US US11/823,068 patent/US20070248697A1/en not_active Abandoned
-
2011
- 2011-02-28 CY CY20111100235T patent/CY1113200T1/el unknown
- 2011-07-28 CY CY2011007C patent/CY2011007I2/el unknown
-
2015
- 2015-12-28 US US14/980,685 patent/US20160106757A1/en not_active Abandoned
-
2018
- 2018-08-21 US US16/106,634 patent/US20180353518A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PT1321144E (pt) | 2011-03-10 |
| EP1321144A1 (en) | 2003-06-25 |
| CN1243548C (zh) | 2006-03-01 |
| CA2422031A1 (en) | 2003-03-12 |
| KR20030029981A (ko) | 2003-04-16 |
| EP1321144A4 (en) | 2009-07-29 |
| US20180353518A1 (en) | 2018-12-13 |
| ES2357551T3 (es) | 2011-04-27 |
| CN1457256A (zh) | 2003-11-19 |
| DE60143615D1 (de) | 2011-01-20 |
| KR100854056B1 (ko) | 2008-08-26 |
| EP1321144B1 (en) | 2010-12-08 |
| NO332650B1 (no) | 2012-11-26 |
| US20070248697A1 (en) | 2007-10-25 |
| CY2011007I1 (el) | 2014-04-09 |
| ATE490761T1 (de) | 2010-12-15 |
| CY1113200T1 (el) | 2014-04-09 |
| AU2001286210A1 (en) | 2002-03-26 |
| WO2002022131A1 (fr) | 2002-03-21 |
| US20160106757A1 (en) | 2016-04-21 |
| NO20031138D0 (no) | 2003-03-12 |
| CA2422031C (en) | 2011-11-15 |
| US20040097592A1 (en) | 2004-05-20 |
| NO20031138L (no) | 2003-05-12 |
| DK1321144T3 (da) | 2011-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2011007I2 (el) | Οφθαλμικες σταγονες | |
| ATE290000T1 (de) | Muscarinagonisten | |
| ATE252099T1 (de) | Biarylcarboxamide | |
| DE10136334B8 (de) | Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser | |
| ATE312098T1 (de) | Thiazinoxazolidinon | |
| ATA2932001A (de) | Schneefräse | |
| DE50114386D1 (de) | Ng | |
| DE50100710D1 (de) | Wischblatt | |
| ATE298751T1 (de) | 7-oxopyridoryrimidine | |
| ATE262530T1 (de) | Indolochinazolinone | |
| DE10192638T1 (de) | Bohrstangenladevorrichtung | |
| AR028336A1 (es) | 4-hidroxi-tetrahidropiridonas fenilsubstituidas | |
| ATE509008T1 (de) | Sulfonylguanidine | |
| DE10196064T1 (de) | Halbleiterfotodektionsgerät | |
| DE50100817D1 (de) | Kugelgelenk | |
| DE50011511D1 (de) | Blowby-Heizung | |
| AR028061A1 (es) | 2-enamino-cetonitrilos fenil-substituidos | |
| DE50007634D1 (de) | Kardioplegieballonkatheter | |
| DE10052925B4 (de) | Schaukelbett | |
| ATE476423T1 (de) | Benzoylpyridazine | |
| DE10195909T1 (de) | Viehfüttervorrichtung | |
| DE10085445T1 (de) | Drahterodierbearbeitungseinrichtung | |
| DE60143209D1 (de) | Zweiport-demodulationseinrichtung | |
| DE10195992T1 (de) | Oberflächenendbearbeitungsbelag | |
| ATE284887T1 (de) | Thienopyrrolidinone |